Skip to main content
Fig. 2 | Cancer Cell International

Fig. 2

From: RETRACTED ARTICLE: Inhibition of ZEB1-AS1 confers cisplatin sensitivity in breast cancer by promoting microRNA-129-5p-dependent ZEB1 downregulation

Fig. 2

ZEB1 and ZEB1-AS1 are the target genes of miR-129-5p. a Verification of the target relationship between miR-129-5p and ZEB1 by dual luciferase reporter gene assay; b identification of the target relationship between miR-129-5p and ZEB1-AS1 by dual luciferase reporter gene assay; c determination of relative ZEB1-AS1 enrichment by RNA pull-down; d determination of relative ZEB1-AS1 enrichment by RNA IP; * indicates p < 0.05 vs. the control group or IgG group. ZEB1-AS1 zinc finger E-box-binding homeobox 1-antisense 1, ZEB1 zinc finger E-box-binding homeobox 1, WT wild type, MUT mutant, miR microRNA, IgG immunoglobulin G, Ago2 argonaute2

Back to article page